Suppr超能文献

腹腔镜下微波消融与射频消融治疗小肝细胞癌(≤3厘米)的比较

Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm).

作者信息

Santambrogio Roberto, Chiang Jason, Barabino Matteo, Meloni Franca Maria, Bertolini Emanuela, Melchiorre Fabio, Opocher Enrico

机构信息

UOC di Chirurgia Epato-bilio-pancreatica e Digestiva, Ospedale San Paolo, Università di Milano, Milan, Italy.

Department of Radiology, University of Wisconsin, Madison, WI, USA.

出版信息

Ann Surg Oncol. 2017 Jan;24(1):257-263. doi: 10.1245/s10434-016-5527-2. Epub 2016 Aug 31.

Abstract

BACKGROUND

Laparoscopic thermal ablation is a common alternative to surgical resection in treating hepatic tumors, particularly in those located in difficult-to-reach locations.

OBJECTIVE

The aim of this study was to compare the safety and long-term efficacy of laparoscopic radiofrequency ablation (RFA) and microwave ablation (MWA) in treating hepatocellular carcinoma (HCC).

METHOD

From February 2009 to May 2015, data from patients with HCC nodules who had undergone either laparoscopic MWA or laparoscopic RFA were examined. Complications, complete ablation rates, local tumor progression (LTP) rates, and disease-free and cumulative survival rates were compared between the two treatment groups.

RESULTS

A total of 154 patients with HCC (60 MWA and 94 RFA) were treated via the laparoscopic approach. Major complication rates were identified as 1 and 2 % in the RFA and MWA groups, respectively (p = 0.747). Complete ablation rates were 95 % for both treatment groups (p = 0.931), and LTP rates were 21.2 % for RFA and 8.3 % for MWA (p = 0.034). Disease-free survival rates at 5 years were 19 % in the RFA group and 12 % in the MWA group (p = 0.434), while cumulative survival rates at 5 years were 50 % in the RFA group and 37 % in the MWA group (p = 0.185).

CONCLUSION

Laparoscopic RFA and MWA appear to be safe in the treatment of early-stage HCC. The LTP rates were lower in the laparoscopic MWA group compared with the laparoscopic RFA group, but their respective overall and disease-free survival rates remained similar.

摘要

背景

腹腔镜热消融是治疗肝肿瘤的一种常见手术切除替代方法,尤其是对于位于难以触及部位的肿瘤。

目的

本研究旨在比较腹腔镜射频消融(RFA)和微波消融(MWA)治疗肝细胞癌(HCC)的安全性和长期疗效。

方法

回顾性分析2009年2月至2015年5月期间接受腹腔镜MWA或腹腔镜RFA治疗的HCC结节患者的数据。比较两组的并发症、完全消融率、局部肿瘤进展(LTP)率、无病生存率和累积生存率。

结果

共有154例HCC患者(60例行MWA,94例行RFA)接受了腹腔镜治疗。RFA组和MWA组的主要并发症发生率分别为1%和2%(p = 0.747)。两组的完全消融率均为95%(p = 0.931),RFA组的LTP率为21.2%,MWA组为8.3%(p = 0.034)。RFA组5年无病生存率为19%,MWA组为12%(p = 0.434);RFA组5年累积生存率为50%,MWA组为37%(p = 0.185)。

结论

腹腔镜RFA和MWA治疗早期HCC似乎是安全的。腹腔镜MWA组的LTP率低于腹腔镜RFA组,但其总体生存率和无病生存率相似。

相似文献

1
Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm).
Ann Surg Oncol. 2017 Jan;24(1):257-263. doi: 10.1245/s10434-016-5527-2. Epub 2016 Aug 31.
4
Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma.
Eur J Radiol. 2013 Sep;82(9):1379-84. doi: 10.1016/j.ejrad.2013.04.025. Epub 2013 May 28.
8
Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Int J Hyperthermia. 2019;36(1):264-272. doi: 10.1080/02656736.2018.1562571. Epub 2019 Jan 24.
9
Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Eur Radiol. 2022 Jul;32(7):4657-4666. doi: 10.1007/s00330-022-08537-5. Epub 2022 Jan 29.

引用本文的文献

1
Development and validation of a prognostic nomogram for early hepatocellular carcinoma treated with microwave ablation.
Front Oncol. 2025 Feb 28;15:1486149. doi: 10.3389/fonc.2025.1486149. eCollection 2025.
7
The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes.
Biomedicines. 2023 Mar 31;11(4):1062. doi: 10.3390/biomedicines11041062.
8
Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma.
Cancers (Basel). 2023 Mar 25;15(7):1965. doi: 10.3390/cancers15071965.
10
Pulsed Microwave Liver Ablation: An Additional Tool to Treat Hepatocellular Carcinoma.
Cancers (Basel). 2022 Jan 31;14(3):748. doi: 10.3390/cancers14030748.

本文引用的文献

3
Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta-analysis.
J Gastroenterol Hepatol. 2016 Feb;31(2):294-301. doi: 10.1111/jgh.13028.
4
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.
World J Hepatol. 2015 May 18;7(8):1054-63. doi: 10.4254/wjh.v7.i8.1054.
5
High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice.
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):349-54. doi: 10.1097/MEG.0000000000000270.
7
Treatment of hepatocellular carcinoma: beyond international guidelines.
Liver Int. 2015 Jan;35 Suppl 1:129-38. doi: 10.1111/liv.12713.
8
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.
Radiology. 2014 Oct;273(1):241-60. doi: 10.1148/radiol.14132958. Epub 2014 Jun 13.
9
Microwave ablation of hepatic malignancy.
Semin Intervent Radiol. 2013 Mar;30(1):56-66. doi: 10.1055/s-0033-1333654.
10
Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up.
Eur J Radiol. 2014 Mar;83(3):552-8. doi: 10.1016/j.ejrad.2013.12.015. Epub 2013 Dec 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验